Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shihao Bao
Institutions:
Tianjin Medical University General Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University General Hospital,
Tianjin Medical University
ORCID:
0009-0009-6714-7318
Observed ORCID:
0009-0009-6714-7318
OpenAlex ID:
A5102666520
Cancer progression and tumor hypercoagulability: a platelet perspective
2024
·
Yifan Zhang
, Jingtong Zeng
, et al.
·
Journal of Thrombosis and Thrombolysis
·
17
HMGB1 secretion by resveratrol in NSCLC: A pathway to ferroptosis-mediated platelet activation suppression
2025
·
Yifan Zhang
, Shihao Bao
, et al.
·
Cellular Signalling
·
9
GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction
2024
·
Jingtong Zeng
, Xianjie Li
, et al.
·
Aging
·
8
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review
2025
·
Hao Zhang
, Wei Xia
, et al.
·
Frontiers in Oncology
·
6
The nomogram for the prediction of overall survival after surgery in patients in early‐stage NSCLC based on SEER database and external validation cohort
2023
·
Hao Zhang
, Jingtong Zeng
, et al.
·
Cancer Medicine
·
6
PDF
Identification of plasminogen activator urokinase receptor-related non-coding RNA and immune prognostic signature for non-small cell lung cancer
2025
·
Yuan Cheng
, Shihao Bao
, et al.
·
Clinics
·
4
Innovative role of the antidepressant imipramine in esophageal squamous cell carcinoma treatment: Promoting apoptosis and protective autophagy
2025
·
Shihao Bao
, Yifan Zhang
, et al.
·
International Immunopharmacology
·
3
Show more works
View as search
Works count:
7
Citation count:
53
H-index:
5
I10-index:
1
Year
Topic
Type